Charlie Bernard Griffin III

Indicted; presumption of innocence. Charlie Bernard Griffin III, a 61-year-old Jacksonville pharmacy owner, has been charged in a 31-count federal indictment with health care fraud and money laundering over an alleged scheme valued at approximately $51 million; he has not been tried or convicted of anything. The indictment’s account of the scheme is a set of allegations by a grand jury, and Griffin is presumed innocent unless and until the government proves guilt beyond a reasonable doubt at trial. A co-defendant, Jacksonville accountant Ethelbert Chinenye Nwanegbo, is charged with money laundering in the same indictment.

Introduction

Charlie Bernard Griffin III is a 61-year-old Jacksonville man charged in a 31-count federal indictment with health care fraud and money laundering, in a scheme the Justice Department values at approximately $51 million. The indictment was announced on Thursday, November 12, 2026, by U.S. Attorney Gregory W. Kehoe of the Middle District of Florida, which also charged Ethelbert Chinenye Nwanegbo, 47, of St. Johns, with money laundering in the same case. Each man faces a maximum penalty of 20 years in prison on each count. Both are charged, not convicted: the allegations remain untested at trial, and both men are presumed innocent unless and until proven guilty.

Background Information

According to the indictment, Griffin owned First Coast Community Development (FCCD), which operated a pharmacy in Jacksonville. Nwanegbo was an accountant in Jacksonville. Prosecutors are also pursuing forfeiture: from Griffin, $14,245,474 representing alleged proceeds of the health care fraud, $17,807,628.14 representing property involved in the money laundering counts, and $8,182,800.17 seized from his bank accounts, along with three real properties and four vehicles said to have been purchased with fraud proceeds; from Nwanegbo, $6,068,540.50. The case was investigated by the Department of Health and Human Services Office of Inspector General, the FBI and IRS Criminal Investigation.

The Controversy or Incident That Led to Their Cancellation

The scheme described here comes from a federal indictment — allegations a grand jury found sufficient to charge, not established facts. Griffin and Nwanegbo have not been tried, and both are presumed innocent unless and until proven guilty beyond a reasonable doubt.

The alleged scheme, as the indictment recounts it, centered on HIV post-exposure prophylactic medications billed to federal and private insurers. Griffin’s FCCD entered into an agreement with a marketing company owned by Jonathan Gholston under which the company referred people to FCCD for HIV medications. Representatives set up tents and tables in Jacksonville, generally in low-income areas, offering free, government-sponsored cellphones to anyone who stopped and agreed to provide identifying information — and, while collecting it, also obtained health insurance details, including whether the person was covered by Medicare, Medicaid or a private insurer.

The agreement paid the marketing company $200 for every person referred for HIV medications, but only if a claim submitted on that person’s behalf was paid; the company in turn paid its representatives, usually $50, on the same paid-claim condition. A marketer’s being paid per referral based upon whether a claim is paid, the release notes, is an illegal kickback. The gathered information went to FCCD and its pharmacist, Albert Chester, and was used to generate prescriptions for HIV medications authorized by Rashan Jones, a nurse practitioner who had never seen, spoken with, or performed any evaluation, examination or test on the people for whom the prescriptions were issued, according to the indictment. To ensure the claims were paid, FCCD falsely used a diagnosis code reflecting that the people had, or had been exposed to, HIV or a sexually transmitted disease — a false diagnosis documented in their medical records — then filled the prescriptions and submitted claims to Medicare, Medicaid and private insurers.

The alleged result: tens of thousands of fraudulent claims and approximately $51 million in reimbursements, of which Griffin is said to have received roughly $14 million. Nwanegbo, per the indictment, received scheme proceeds into accounts he controlled, transferred the funds to other accounts, and returned them to Griffin and a co-conspirator through transfers, deposits and cash payments, retaining a money laundering fee of approximately 10 percent. Gholston, Chester and Jones were previously charged separately, and each of them agreed to plead guilty.

Public Reaction and Consequences

The case was announced as part of the department’s fraud-enforcement push: the release notes that on April 7 the Justice Department created the National Fraud Enforcement Division, “laser-focused on investigating and prosecuting those who commit fraud against the American people,” in support of President Trump’s Task Force to Eliminate Fraud, a whole-of-government effort chaired by Vice President J.D. Vance. Kehoe’s announcement detailed the forfeiture demands — more than $40 million in alleged proceeds, laundering-involved property and seized funds from Griffin alone, plus three real properties and four vehicles — signaling the government’s intent to strip the alleged gains if the charges are proven. The release includes no statement from Griffin or Nwanegbo and no comment from defense counsel, and the $51 million figure stands, for now, as the government’s untested allegation.

Current Status

Griffin and Nwanegbo have been charged but not tried; the release announcing the indictment on November 12, 2026, reports no arraignment date, plea or trial schedule for either man. The prosecution is handled by Assistant United States Attorney Arnold B. Corsmeier, with the forfeiture work handled by Assistant United States Attorney Clint Locke. Three alleged participants — Gholston, Chester and Jones — have already agreed to plead guilty on separate charges, a development likely to shape the case against the two men named in the 31-count indictment. Until the case resolves, both remain presumed innocent and the counts stand as accusations.

Impact on Their Career/Life

If convicted, Griffin faces a maximum penalty of 20 years in prison on each count, plus the government’s sought forfeiture of roughly $40 million in funds and property and the loss of the pharmacy operation the indictment ties to the alleged scheme by name. Nwanegbo faces the same per-count maximum and a $6 million forfeiture demand. The indictment has publicly attached the alleged mechanics — tent-side harvesting of personal data, prescriptions authorized without examinations, tens of millions in claims — to Griffin’s business and Nwanegbo’s accounting work, and the planned guilty pleas of three co-charged participants will keep the case in public view as it moves toward resolution.

Sources

  • U.S. Attorney’s Office, Middle District of Florida, “Jacksonville Pharmacy Owner and Accountant Indicted in $51 Million Health Care Fraud Scheme” (Nov. 12, 2026) — source
Page updated: November 12, 2026